blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2452686

EP2452686 - Methods and compositions for prevention and treatment of diabetic and aged skin [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.03.2014
Database last updated on 03.09.2024
Most recent event   Tooltip21.03.2014Application deemed to be withdrawnpublished on 23.04.2014  [2014/17]
Applicant(s)For all designated states
HealOr Ltd.
Ruhrberg Science Building
Graham Bell Entrance, Floor 5
3 Pekeris Street
76702 Rehovot / IL
[2012/20]
Inventor(s)01 / Tennenbaum, Tamar
12 Herzl Boulevard
IL-96105 Jerusalem / IL
02 / Braiman-Wiksman, Liora
24 Stephan Weiss Street
IL-75400 Rishon Lezion / IL
03 / Solomonik, Inessa
3 HaMizpa Street
IL-55900 Ganei Tikva / IL
04 / Meir, Michael
19 Yehuda Karni Street
IL-69025 Tel Aviv / IL
 [2012/20]
Representative(s)Helbig, Christian
Wagner + Helbig Patentanwälte Pfarrstrasse 14
80538 München / DE
[2012/20]
Application number, filing date11189741.929.08.2006
[2012/20]
Priority number, dateUS20050711666P29.08.2005         Original published format: US 711666 P
[2012/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2452686
Date:16.05.2012
Language:EN
[2012/20]
Type: A3 Search report 
No.:EP2452686
Date:05.09.2012
Language:EN
[2012/36]
Search report(s)(Supplementary) European search report - dispatched on:EP02.08.2012
ClassificationIPC:A61K35/12, A61K38/00
[2012/20]
CPC:
A61K38/28 (EP,US); A61K31/427 (EP,US); A61K31/445 (EP,US);
A61K38/02 (EP,US); A61K38/085 (EP,US); A61K38/1709 (EP,US);
A61K38/191 (EP,US); A61K38/2006 (EP,US); A61K38/2026 (EP,US);
A61K38/204 (EP,US); A61K38/2053 (EP,US); A61K38/2264 (EP,US);
A61K38/2271 (EP,US); A61K38/45 (EP,US); A61K38/4886 (EP,US);
A61K38/57 (EP,US); A61P17/00 (EP); A61P17/16 (EP);
A61P17/18 (EP); A61P3/10 (EP); A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/20]
Extension statesAL18.11.2011
BA18.11.2011
HR18.11.2011
MK18.11.2011
RS18.11.2011
TitleGerman:Verfahren und Zusammensetzungen zur Vorbeugung und Behandlung von diabetischer und alternder Haut[2012/20]
English:Methods and compositions for prevention and treatment of diabetic and aged skin[2012/20]
French:Procédés et compositions pour la prévention et le traitement du diabète et du vieillissement de la peau[2012/20]
Examination procedure18.11.2011Examination requested  [2012/20]
01.03.2013Amendment by applicant (claims and/or description)
07.05.2013Despatch of a communication from the examining division (Time limit: M06)
19.11.2013Application deemed to be withdrawn, date of legal effect  [2014/17]
12.12.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/17]
Parent application(s)   TooltipEP06780442.7  / EP1940440
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060780442) is  19.11.2009
Fees paidRenewal fee
18.11.2011Renewal fee patent year 03
18.11.2011Renewal fee patent year 04
18.11.2011Renewal fee patent year 05
18.11.2011Renewal fee patent year 06
27.08.2012Renewal fee patent year 07
27.08.2013Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO0209639  (UNIV BAR ILAN [IL], et al) [Y] 1,2,5-15 * claims 1,3 *;
 [XY]WO2005007072  (UNIV BAR ILAN [IL], et al) [X] 1,2,7-15 * examples 22-25 * * page 9, paragraph 3; example 25 * [Y] 5,6;
 [XY]WO2005009437  (BETHESDA PHARMACEUTICALS INC [US], et al) [X] 1,2,7-15 * paragraphs [0009] , [0 14] , [0 76] * [Y] 5,6;
 [XY]WO2005013885  (HEALOR LTD [IL], et al) [X] 1,2,7-15 * page 1, paragraph 23; claims 17-18, 67-70 * * page 30, line 30 - line 32 * [Y] 5,6;
 [XY]  - C N Ellis ET AL, "Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation.", Arch Dermatol. 136(5), (20000501), pages 609 - 616, URL: http://archderm.ama-assn.org/cgi/reprint/136/5/609.pdf, (20120402), XP055023556 [X] 1,2,7-15 * the whole document * * page 613, column l * [Y] 5,6

DOI:   http://dx.doi.org/10.1001/archderm.136.5.609
 [Y]  - FERRINGER T ET AL, "CUTANEOUS MANIFESTATIONS OF DIABETES MELLITUS", DERMATOLOGIC CLINICS, W.B. SAUNDERS CO., LONDON, GB, (20020101), vol. 20, no. 3, doi:10.1016/S0733-8635(02)00018-9, ISSN 0733-8635, pages 483 - 492, XP008011468 [Y] 1,2,5-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0733-8635(02)00018-9
 [T]  - MICHALIK ET AL, "Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease", BIOCHIMICA AND BIOPHYSICA ACTA. MOLECULAR AND CELL BIOLOGY OF LIPIDS, ELSEVIER, AMSTERDAM, NL, (20070807), vol. 1771, no. 8, doi:10.1016/J.BBALIP.2007.02.004, ISSN 1388-1981, pages 991 - 998, XP022189884 [T] * the whole document * * page 996, column l *

DOI:   http://dx.doi.org/10.1016/j.bbalip.2007.02.004
by applicantWO0209639
 WO2005007072
 WO2005013885
    - Remington's Pharmaceutical Sciences, MACK PUBLISHING CO.
    - Remington: The Science and Practice of Pharmacy, 19th Ed., MACK PUBLISHING CO., (1995), pages 1399 - 1404
    - ALT, A. OHBA; M. LI; L. GARTSBEIN; M. BELANGER; A. DENNING; M.F. KUROKI; T. YUSPA; S.H. TENNENBAUM, T., "Protein kinase Cdelta-mediated phosphorylation of alpha6beta4 is associated with reduced integrin localization to the hemidesmosome and decreased keratinocyte attachment", CANCER RES., (2001), vol. 61, pages 4591 - 4598
    - BENES, C.H. WU; N. ELIA; A.E.H. DHARIA; T. CANTLEY; L.C.SOLTOFF, S.P., "The C2 domain of PKC6 is a phosphotyrosine binding domain", CELL, (2005), vol. 121, pages 271 - 280
    - CHANG, L. CHIANG; S.H. SALTIEL, A.R., "Insulin signaling and the regulation of glucose transport", MOL MED., (2004), vol. 10, pages 65 - 71, XP002490816
    - CONNERY, L.E.; COURSIN, D.B., "Assessment and therapy of selected endocrine disorders", ANESTHESIOL. CLIN. NORTH AMERICA, (2004), vol. 22, pages 93 - 123
    - ELIAS, P.M.; GHADIALLY, R., "The aged epidermal permeability barrier: basis for functional abnormalities", CLIN GERIATRMED., (2002), vol. 18, doi:doi:10.1016/S0749-0690(03)00037-5, pages 103 - 120, XP009114232

DOI:   http://dx.doi.org/10.1016/S0749-0690(03)00037-5
    - FARESE, R.V.; SAJAN, M.P.; STANDAERT, M.L., "Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes", EXP BIOI MED, (2005), vol. 230, pages 593 - 605
    - FLIERS, E.; KREIER, F.; VOSHOL, P.J.; HAVEKES, L.M.; SAUERWEIN, H.P.; KALSBEEK, A.; BUIJS, R.M.; ROMIJN, J.A.; WHITE ADIPOSE TISSU, J NEUROENDOCRINOL., (2003), vol. 15, pages 1005 - 1010
    - FORMISANO, P.; ORIENTY, F.; FIORY, F.; CARUSO, M.; MIELE, C.; MAITAN, M.A.; ANDREOZZI, F.; VIGLIOTTA, G.; CONDORELLI, G.; BEGUINOT, "Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells", MOL CELL BIOL., (2000), vol. 20, pages 6323 - 6333
    - GARTSBEIN, M.; ALT, A.; HASHIMOTO, K.; NAKAJIMA, K.; KUROKI, T.; TENNENBAUM, T., "The role of protein kinase C delta activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferation", J CELL SCI., (2006), vol. 119, pages 470 - 481
    - GREGOIRE, F.M., "Adipocyte differentiation: from fibroblast to endocrine cell", EXP BIOL MED, (2001), vol. 226, pages 997 - 1002
    - HOFMANN, J., "The potential for isoenzyme-selective modulation of protein kinase C", THE FASEB J, (1997), vol. 11, pages 649 - 669
    - ISHIKI, M.; KLIP, A., "Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners", ENDOCRINOLOGY, (2005), vol. 146, pages 5071 - 5078
    - JACKSON, S.M.; WILLIAMS, M.L.; FEINGOLD K.R.; ELIAS, P.M., "Pathobiology of the stratum corneum", WEST JMED., (1993), vol. 158, pages 279 - 285
    - LAVIOLA, L.; PERRINI, S.; CIGNARELLI, A.; GIORGINO, F., "Insulin signalling in human adipose tissue", ARCH PHYSIOL BIOCHEM., (2006), vol. 112, pages 82 - 88
    - MAIANU, L.; KELLER, S.R.; GARVEY, W.T., "Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking", J CLIN ENDOCRINOL METAB., (2001), vol. 86, pages 5450 - 5456
    - MONTAGNA, W.; CARLISLE, K., "Structural changes in aging human skin", J INVEST DERMATOL., (1979), vol. 73, pages 47 - 53
    - MULLER, L.M.; GORTER, K.J.; HAK, E.; GOUDZWAARD, W.L.; SCHELLEVIS, F.G.; HOEPELMAN, A.I.; RUTTEN, G.E., "Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus", CLIN INFECT DIS., (2005), vol. 41, pages 281 - 288
    - NG, T.; PARSONS, M.; HUGHES, W.E.; MONYPENNY, J.; ZICHA, D.; GAUTREAU, A.; ARPIN, M.; GSCHMEISSNER, S.; VERVEER, P.J.; BASTIAENS,, "Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility", EMBO J., (2001), vol. 20, pages 2723 - 2741
    - PANTANETTI, P.; GARRAPA, G.G.; MANTERO, F.; BOSCARO, M.; FALOIA, E.; VENARUCCI, D., "Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions", CLIN EXP HYPERTENS., (2004), vol. 26, pages 387 - 398
    - PATEL, N.; HUANG, C.; KLIP, A., "Cellular location of insulin-triggered signals and implications for glucose uptake", PFLUGERS ARCH., (2006), vol. 451, doi:doi:10.1007/s00424-005-1475-6, pages 499 - 510, XP019344109

DOI:   http://dx.doi.org/10.1007/s00424-005-1475-6
    - "Structure and dynamics of the skin barrier", SCHAEFER, H.; REDELMEIER, T.E., Skin barrier: principles of percutaneous absorption, (1996), pages 1 - 42
    - SHEN, S.; ALT, A.; WERTHEIMER, E.; GARTSBEIN, M.; KUROKI, T.; OHBA, M.; BRAIMAN, L.; SAMPSON, S.R.; TENNENBAUM, T., "PKCdelta activation: a divergence point in the signaling of insulin and IGF-1-induced proliferation of skin keratinocytes", DIABETES, (2001), vol. 50, doi:doi:10.2337/diabetes.50.2.255, pages 255 - 264, XP002223026

DOI:   http://dx.doi.org/10.2337/diabetes.50.2.255
    - SPRAVCHIKOV, N.; SIZYAKOV, G.; GARTSBEIN, M.; ACCILI, D.; TENNENBAUM, T.; WERTHEIMER, E., "Glucose effects on skin keratinocytes: implications for diabetes skin complications", DIABETES, (2000), vol. 50, doi:doi:10.2337/diabetes.50.7.1627, pages 1627 - 1635, XP002223027

DOI:   http://dx.doi.org/10.2337/diabetes.50.7.1627
    - TAHA, C.; KLIP, A., "The insulin signaling pathway", J MEMBRANE BIOL., (1999), vol. 169, pages 1 - 12
    - TENNENBAUM, T.; YUSPA, S.H.; KNOX, B.; SOBEL, M.E.; CASTRONOVO, V.; YAMADA, Y.; DE LUCA, L.M., "Alterations in attachment to laminin and localization of laminin binding proteins during differentiation of primary mouse keratinocytes in vitro (Abstract", J INVEST. DERMATOL., (1991), page 96
    - TINGO, X.T.; DIMG, S.Y.; HANSEN, B.C., "Paradoxical increase in dermal microvascular flow in pre-diabetes associated with elevated levels of CRP", CLIN HEMORHEOL MICROCIRC., (2006), vol. 34, pages 273 - 282
    - VARANI, J.; DAME, M.K.; RITTIE, L.; FLIGIEL, S.E.; KANG, S.; FISHER, G.J.; VOORHEES, J.J., "Decreased collagen production in chronologically aged skin: roles of age- dependent alteration in fibroblast function and defective mechanical stimulation", AM J PATHOL., (2006), vol. 168, pages 1861 - 1868
    - WANG, Y.R.; MARGOLIS, D., "The prevalence of diagnosed cutaneous manifestations during ambulatory diabetes visits in the United States", DERMATOLOGY, (1998), vol. 212, pages 229 - 234
    - WERTHEIMER, E.; SPRAVCHIKOV, N.; TREBICZ, M.; GARTSBEIN, M.; ACCILI, D.; AVINOAH, I.; NOFEH-MOSES, S.; SIZYAKOV, G.; TENNENBAUM, T, "The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes", ENDOCRINOLOGY, (2001), vol. 142, doi:doi:10.1210/en.142.3.1234, pages 1234 - 1241, XP002223028

DOI:   http://dx.doi.org/10.1210/en.142.3.1234
    - WERTHEIMER, E., "Diabetic skin complications: a need for reorganizing the categories of diabetes-associated complications", ISR. MED ASSOC. J, (2004), vol. 6, pages 287 - 289
    - WEST, M.D., "The cellular and molecular biology of skin aging", ARCH DERMATOL., (1994), vol. 130, pages 87 - 95
    - WHITE, M.F., "The insulin signalling system and the IRS proteins", DIABETOLOGIA, (1997), vol. 40, no. 2, pages 2 - 17
    - WYSOCKI, A.B., "Skin, anatomy, physiology, and pathophysiology", NURS. CLIN. NORTH AM., (1999), vol. 34, pages 777 - 797
    - YANG, S.; LITCHFIELD, J.E.; BAYNES, J.W., "AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats", ARCH BIOCHEM BIOPHYS., (2003), vol. 412, pages 42 - 46
    - YOON, H.S.; BAIK, S.H.; OH, C.H., "Quantitative measurement of desquamation and skin elasticity in diabetic patients", SKIN RES TECHNOL., (2002), vol. 8, pages 250 - 254
    - YUSPA, S.H.; KILKENNY, A.E.; STEINERT, P.M.; ROOP, D.R., "Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro", J CELL BIOL., (1989), vol. 109, doi:doi:10.1083/jcb.109.3.1207, pages 1207 - 1217, XP002520093

DOI:   http://dx.doi.org/10.1083/jcb.109.3.1207
 US20000629970
 US20020169801
 US20060332774
 US20060348527
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.